David AuCoin cofounded DxDiscovery and currently serves as the company’s Chief Executive Officer. Dr. AuCoin is also a Professor and Chair of Microbiology and Immunology at the University of Nevada School of Medicine. He has nearly 25 years experience in the study of viral, bacterial and fungal immunology and pathogenesis. Currently, his research is focused on developing diagnostics and therapeutics for microbial infections. Dr. AuCoin has received multiple research grants and contracts from the National Institutes of Health and the Department of Defense. Dr. AuCoin received his B.S. from the University of Massachusetts at Amherst followed by his M.S. and Ph.D. in Cell and Molecular Biology from the University of Nevada. Dr. AuCoin completed a postdoctoral fellowship at Stanford University 2005.